Sign inJoin waitlistJoin the waitlist

Suman Jayadev

Associate Director, Medical… · University of Washington School of Medicine

Credentials: · · · ·

History

UW Neurogenetics Clinic/ UW Huntington Disease Center of Excellence · University of Washington School of Medicine
Present
Department of Neurology · University of Washington School of Medicine
Present
Research · University of Washington School of Medicine
Present

Neurology
University of Washington-Seattle Campus
2002–2005
New York Medical College
1996–2000

Research

Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha
Journal of Biological Chemistry · 1994 · First of 3 authors · 305 citations
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Nature Medicine · 2021 · 305 citations
Integrated multimodal cell atlas of Alzheimer's disease
Nature Neuroscience · 2024 · 287 citations

Thomas Bird
32 papers
Dirk Keene
24 papers
Gwenn Garden
19 papers · 1 as a resident
Caitlin Latimer
17 papers · 1 as a fellow
Kimiko Domoto-Reilly
11 papers
Thomas Grabowski
9 papers
Douglas Galasko
8 papers
Debby Tsuang
7 papers
Elaine Peskind
7 papers
EM
Eric McDade
7 papers
Erika Roberson
7 papers
Lawrence Honig
7 papers · 5 as a resident

Grants

University of Washington Alzheimer's Disease Research Center
National Institute on Aging · P30
Project lead · $7.1M · University of Washington
2020–2030
Characterization of AD-Related Endolysosomal Dysfunction in Human Neural Cells
National Institute on Aging · R01
PI · $2.5M · University of Washington
2024–2029
Dissecting the Role of Sex-Linked Genes and APOE e4 Risk in AD
National Institute on Aging · R01
PI · $5.9M · University of Washington
2021–2027
Illuminating Early Microglial Dysfunction in Alzheimer's Disease Through Integration of Explainable AI and iPSC Models
National Institute on Aging · R21
Contact PI · $422.5K · University of Washington
2024–2027

Clinical trials

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test
Principal investigator · Completed
Optina Diagnostics Inc.
2022–2024
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2026–2030
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034